US Stock MarketDetailed Quotes

ABOS Acumen Pharmaceuticals

Watchlist
  • 1.790
  • +0.020+1.13%
Close Dec 24 13:00 ET
107.54MMarket Cap-1.30P/E (TTM)

Acumen Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-90.59%-24.6M
-41.77%-16.55M
-75.52%-17.86M
-22.50%-43.06M
25.79%-8.31M
-40.53%-12.91M
-80.43%-11.67M
-22.61%-10.18M
-95.72%-35.15M
-207.86%-11.2M
Net income from continuing operations
-129.72%-29.77M
-76.89%-20.54M
-31.54%-14.87M
-22.20%-52.37M
-28.22%-16.5M
-20.98%-12.96M
-14.37%-11.61M
-23.86%-11.31M
57.40%-42.86M
-54.10%-12.87M
Operating gains losses
---85K
---1.1M
--48K
--1.35M
----
----
----
----
----
----
Depreciation and amortization
12.50%45K
-15.09%45K
-15.38%44K
8.88%184K
-20.41%39K
-9.09%40K
35.90%53K
40.54%52K
4,125.00%169K
1,533.33%49K
Other non cash items
--514K
--271K
--268K
--884K
----
----
----
----
----
----
Change In working capital
525.28%3.73M
382.23%3.77M
-17,045.83%-4.07M
-3.01%3.87M
643.73%6.05M
-294.25%-878K
-148.32%-1.33M
158.54%24K
1,237.58%3.99M
-80.01%814K
-Change in prepaid assets
-156.51%-846K
-202.13%-3.12M
74.86%-226K
-121.71%-369K
118.72%67K
222.30%1.5M
-155.41%-1.03M
-163.49%-899K
143.80%1.7M
-186.06%-358K
-Change in payables and accrued expense
292.31%4.55M
2,895.18%6.96M
-481.29%-3.83M
71.80%4.4M
373.90%6.01M
-239.56%-2.37M
-126.05%-249K
173.90%1.01M
-38.95%2.56M
-65.33%1.27M
-Change in other current assets
205.26%58K
-223.08%-42K
179.55%35K
48.91%-70K
45.76%-32K
35.71%19K
51.85%-13K
32.31%-44K
-878.57%-137K
-5,800.00%-59K
-Change in other current liabilities
-11.11%-30K
23.68%-29K
-15.79%-44K
32.12%-93K
127.03%10K
20.59%-27K
-11.76%-38K
-18.75%-38K
---137K
---37K
Cash from discontinued investing activities
Operating cash flow
-90.59%-24.6M
-41.77%-16.55M
-75.52%-17.86M
-22.50%-43.06M
25.79%-8.31M
-40.53%-12.91M
-80.43%-11.67M
-22.61%-10.18M
-95.72%-35.15M
-207.86%-11.2M
Investing cash flow
Cash flow from continuing investing activities
88.99%-10.13M
240.74%37.7M
78.05%-9.2M
-538.10%-171.67M
-139.02%-48.81M
-264.53%-92M
25.94%11.06M
-722.26%-41.93M
137.63%39.19M
-103.98%-20.42M
Net PPE purchase and sale
--0
---5K
---11K
88.82%-18K
60.00%-14K
95.06%-4K
--0
--0
-302.50%-161K
-34.62%-35K
Net investment purchase and sale
88.99%-10.13M
240.78%37.7M
78.08%-9.19M
-536.27%-171.65M
-139.36%-48.79M
-264.28%-92M
25.43%11.06M
-723.71%-41.93M
137.80%39.35M
-104.16%-20.39M
Cash from discontinued investing activities
Investing cash flow
88.99%-10.13M
240.74%37.7M
78.05%-9.2M
-538.10%-171.67M
-139.02%-48.81M
-264.53%-92M
25.94%11.06M
-722.26%-41.93M
137.63%39.19M
-103.98%-20.42M
Financing cash flow
Cash flow from continuing financing activities
-100.03%-42K
11.72%-128K
7.11M
3,784.13%151.75M
596.32%29.13M
46,778.33%122.76M
-145K
0
-98.05%3.91M
41,740.00%4.18M
Net issuance payments of debt
--0
--0
---739K
--30M
--30M
--0
--0
--0
--0
----
Net common stock issuance
--0
--0
--7.91M
3,114.77%121.9M
-110.28%-390K
--122.29M
--0
--0
-97.75%3.79M
126,500.00%3.79M
Proceeds from stock option exercised by employees
----
----
----
182.61%325K
--0
----
----
----
-93.88%115K
638.46%96K
Net other financing activities
---42K
---128K
---60K
---476K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-100.03%-42K
11.72%-128K
--7.11M
3,784.13%151.75M
596.32%29.13M
46,778.33%122.76M
---145K
--0
-98.05%3.91M
41,740.00%4.18M
Net cash flow
Beginning cash position
-11.73%68.19M
-39.53%47.16M
-48.41%67.12M
6.50%130.1M
-39.63%95.11M
-30.45%77.25M
-28.29%78M
6.50%130.1M
179.06%122.16M
16.01%157.54M
Current changes in cash
-294.70%-34.77M
2,899.73%21.03M
61.70%-19.96M
-893.32%-62.98M
-2.00%-27.99M
-61.57%17.86M
-132.61%-751K
-288.88%-52.1M
-89.87%7.94M
-101.17%-27.44M
End cash Position
-64.86%33.42M
-11.73%68.19M
-39.53%47.16M
-48.41%67.12M
-48.41%67.12M
-39.63%95.11M
-30.45%77.25M
-28.29%78M
6.50%130.1M
6.50%130.1M
Free cash flow
-90.49%-24.6M
-41.82%-16.55M
-75.63%-17.87M
-22.01%-43.09M
25.89%-8.33M
-39.38%-12.91M
-79.43%-11.67M
-22.47%-10.18M
-96.18%-35.31M
-206.63%-11.24M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -90.59%-24.6M-41.77%-16.55M-75.52%-17.86M-22.50%-43.06M25.79%-8.31M-40.53%-12.91M-80.43%-11.67M-22.61%-10.18M-95.72%-35.15M-207.86%-11.2M
Net income from continuing operations -129.72%-29.77M-76.89%-20.54M-31.54%-14.87M-22.20%-52.37M-28.22%-16.5M-20.98%-12.96M-14.37%-11.61M-23.86%-11.31M57.40%-42.86M-54.10%-12.87M
Operating gains losses ---85K---1.1M--48K--1.35M------------------------
Depreciation and amortization 12.50%45K-15.09%45K-15.38%44K8.88%184K-20.41%39K-9.09%40K35.90%53K40.54%52K4,125.00%169K1,533.33%49K
Other non cash items --514K--271K--268K--884K------------------------
Change In working capital 525.28%3.73M382.23%3.77M-17,045.83%-4.07M-3.01%3.87M643.73%6.05M-294.25%-878K-148.32%-1.33M158.54%24K1,237.58%3.99M-80.01%814K
-Change in prepaid assets -156.51%-846K-202.13%-3.12M74.86%-226K-121.71%-369K118.72%67K222.30%1.5M-155.41%-1.03M-163.49%-899K143.80%1.7M-186.06%-358K
-Change in payables and accrued expense 292.31%4.55M2,895.18%6.96M-481.29%-3.83M71.80%4.4M373.90%6.01M-239.56%-2.37M-126.05%-249K173.90%1.01M-38.95%2.56M-65.33%1.27M
-Change in other current assets 205.26%58K-223.08%-42K179.55%35K48.91%-70K45.76%-32K35.71%19K51.85%-13K32.31%-44K-878.57%-137K-5,800.00%-59K
-Change in other current liabilities -11.11%-30K23.68%-29K-15.79%-44K32.12%-93K127.03%10K20.59%-27K-11.76%-38K-18.75%-38K---137K---37K
Cash from discontinued investing activities
Operating cash flow -90.59%-24.6M-41.77%-16.55M-75.52%-17.86M-22.50%-43.06M25.79%-8.31M-40.53%-12.91M-80.43%-11.67M-22.61%-10.18M-95.72%-35.15M-207.86%-11.2M
Investing cash flow
Cash flow from continuing investing activities 88.99%-10.13M240.74%37.7M78.05%-9.2M-538.10%-171.67M-139.02%-48.81M-264.53%-92M25.94%11.06M-722.26%-41.93M137.63%39.19M-103.98%-20.42M
Net PPE purchase and sale --0---5K---11K88.82%-18K60.00%-14K95.06%-4K--0--0-302.50%-161K-34.62%-35K
Net investment purchase and sale 88.99%-10.13M240.78%37.7M78.08%-9.19M-536.27%-171.65M-139.36%-48.79M-264.28%-92M25.43%11.06M-723.71%-41.93M137.80%39.35M-104.16%-20.39M
Cash from discontinued investing activities
Investing cash flow 88.99%-10.13M240.74%37.7M78.05%-9.2M-538.10%-171.67M-139.02%-48.81M-264.53%-92M25.94%11.06M-722.26%-41.93M137.63%39.19M-103.98%-20.42M
Financing cash flow
Cash flow from continuing financing activities -100.03%-42K11.72%-128K7.11M3,784.13%151.75M596.32%29.13M46,778.33%122.76M-145K0-98.05%3.91M41,740.00%4.18M
Net issuance payments of debt --0--0---739K--30M--30M--0--0--0--0----
Net common stock issuance --0--0--7.91M3,114.77%121.9M-110.28%-390K--122.29M--0--0-97.75%3.79M126,500.00%3.79M
Proceeds from stock option exercised by employees ------------182.61%325K--0-------------93.88%115K638.46%96K
Net other financing activities ---42K---128K---60K---476K------------------------
Cash from discontinued financing activities
Financing cash flow -100.03%-42K11.72%-128K--7.11M3,784.13%151.75M596.32%29.13M46,778.33%122.76M---145K--0-98.05%3.91M41,740.00%4.18M
Net cash flow
Beginning cash position -11.73%68.19M-39.53%47.16M-48.41%67.12M6.50%130.1M-39.63%95.11M-30.45%77.25M-28.29%78M6.50%130.1M179.06%122.16M16.01%157.54M
Current changes in cash -294.70%-34.77M2,899.73%21.03M61.70%-19.96M-893.32%-62.98M-2.00%-27.99M-61.57%17.86M-132.61%-751K-288.88%-52.1M-89.87%7.94M-101.17%-27.44M
End cash Position -64.86%33.42M-11.73%68.19M-39.53%47.16M-48.41%67.12M-48.41%67.12M-39.63%95.11M-30.45%77.25M-28.29%78M6.50%130.1M6.50%130.1M
Free cash flow -90.49%-24.6M-41.82%-16.55M-75.63%-17.87M-22.01%-43.09M25.89%-8.33M-39.38%-12.91M-79.43%-11.67M-22.47%-10.18M-96.18%-35.31M-206.63%-11.24M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+7.36%
Broadcom
AVGO
+3.15%
Netflix
NFLX
+2.27%
Amazon
AMZN
+1.77%
Cisco
CSCO
+1.48%

Unlock the Full List